143 related articles for article (PubMed ID: 25425197)
1. Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation.
De Falco F; Sabatini R; Falzetti F; Di Ianni M; Sportoletti P; Baldoni S; Del Papa B; Screpanti I; Marconi P; Rosati E
Leukemia; 2015 Apr; 29(4):994-8. PubMed ID: 25425197
[No Abstract] [Full Text] [Related]
2. Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia.
Gowda C; Soliman M; Kapadia M; Ding Y; Payne K; Dovat S
Adv Biol Regul; 2017 Aug; 65():16-25. PubMed ID: 28623166
[TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation.
Onaindia A; Gómez S; Piris-Villaespesa M; Martínez-Laperche C; Cereceda L; Montes-Moreno S; Batlle A; de Villambrosia SG; Pollán M; Martín-Acosta P; González-Rincón J; Menarguez J; Alvés J; Rodriguez-Pinilla SM; García JF; Mollejo M; Fraga M; García-Marco JA; Piris MA; Sánchez-Beato M
Haematologica; 2015 May; 100(5):e200-3. PubMed ID: 25552700
[No Abstract] [Full Text] [Related]
4. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.
Palomero T; Sulis ML; Cortina M; Real PJ; Barnes K; Ciofani M; Caparros E; Buteau J; Brown K; Perkins SL; Bhagat G; Agarwal AM; Basso G; Castillo M; Nagase S; Cordon-Cardo C; Parsons R; Zúñiga-Pflücker JC; Dominguez M; Ferrando AA
Nat Med; 2007 Oct; 13(10):1203-10. PubMed ID: 17873882
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia.
Xu ZS; Zhang JS; Zhang JY; Wu SQ; Xiong DL; Chen HJ; Chen ZZ; Zhan R
Oncol Rep; 2015 Apr; 33(4):1609-14. PubMed ID: 25633905
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia.
Rasi S; Khiabanian H; Ciardullo C; Terzi-di-Bergamo L; Monti S; Spina V; Bruscaggin A; Cerri M; Deambrogi C; Martuscelli L; Biasi A; Spaccarotella E; De Paoli L; Gattei V; Foà R; Rabadan R; Gaidano G; Rossi D
Haematologica; 2016 Apr; 101(4):e135-8. PubMed ID: 26819056
[No Abstract] [Full Text] [Related]
7. NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways.
Benedetti D; Tissino E; Pozzo F; Bittolo T; Caldana C; Perini C; Martorelli D; Bravin V; D'Agaro T; Rossi FM; Bomben R; Santinelli E; Zaja F; Pozzato G; Chiarenza A; Di Raimondo F; Del Poeta G; Rossi D; Gaidano G; Dal Bo M; Gattei V; Zucchetto A
Leukemia; 2018 Mar; 32(3):654-662. PubMed ID: 28935990
[TBL] [Abstract][Full Text] [Related]
8. Common nonmutational
Fabbri G; Holmes AB; Viganotti M; Scuoppo C; Belver L; Herranz D; Yan XJ; Kieso Y; Rossi D; Gaidano G; Chiorazzi N; Ferrando AA; Dalla-Favera R
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2911-E2919. PubMed ID: 28314854
[TBL] [Abstract][Full Text] [Related]
9. GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL.
De Falco F; Rompietti C; Sorcini D; Esposito A; Scialdone A; Baldoni S; Del Papa B; Adamo FM; Silva Barcelos EC; Dorillo E; Stella A; Di Ianni M; Screpanti I; Sportoletti P; Rosati E
Cell Death Dis; 2022 Sep; 13(9):755. PubMed ID: 36050315
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1.
Liu ZJ; Xiao M; Balint K; Soma A; Pinnix CC; Capobianco AJ; Velazquez OC; Herlyn M
FASEB J; 2006 May; 20(7):1009-11. PubMed ID: 16571776
[TBL] [Abstract][Full Text] [Related]
11. Diminished interaction between mutant NOTCH1 and the NuRD corepressor complex upregulates CCL17 in chronic lymphocytic leukemia.
Wang S; Ge M; Cui J; Qiao Z; Chen X; Wu S; Zhan R; Zhou H; Liu H; Xu Z
Leukemia; 2019 Dec; 33(12):2951-2956. PubMed ID: 31341237
[No Abstract] [Full Text] [Related]
12. NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components.
Pozzo F; Bittolo T; Vendramini E; Bomben R; Bulian P; Rossi FM; Zucchetto A; Tissino E; Degan M; D'Arena G; Di Raimondo F; Zaja F; Pozzato G; Rossi D; Gaidano G; Del Poeta G; Gattei V; Dal Bo M
Leukemia; 2017 Nov; 31(11):2407-2415. PubMed ID: 28321119
[TBL] [Abstract][Full Text] [Related]
13. PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration.
Liu J; Zhang Y; Xu R; Du J; Hu Z; Yang L; Chen Y; Zhu Y; Gu L
Cell Signal; 2013 Feb; 25(2):447-56. PubMed ID: 23123500
[TBL] [Abstract][Full Text] [Related]
14. PKR activity is required for acute leukemic cell maintenance and growth: a role for PKR-mediated phosphatase activity to regulate GSK-3 phosphorylation.
Blalock WL; Grimaldi C; Fala F; Follo M; Horn S; Basecke J; Martinelli G; Cocco L; Martelli AM
J Cell Physiol; 2009 Oct; 221(1):232-41. PubMed ID: 19507191
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
16. Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells.
Shimizu T; Kagawa T; Inoue T; Nonaka A; Takada S; Aburatani H; Taga T
Mol Cell Biol; 2008 Dec; 28(24):7427-41. PubMed ID: 18852283
[TBL] [Abstract][Full Text] [Related]
17. NOTCH1 mutation in type II Hodgkin transformation of chronic lymphocytic leukemia.
McGovern B; Quinn F; Andrews C; Jeffers M; Bacon CL; Bird B; Crotty G; Vandenberghe E; Flavin R
Leuk Lymphoma; 2017 Mar; 58(3):732-735. PubMed ID: 27686521
[No Abstract] [Full Text] [Related]
18. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase B/Akt phosphorylates and inhibits the cardiac Na+/H+ exchanger NHE1.
Snabaitis AK; Cuello F; Avkiran M
Circ Res; 2008 Oct; 103(8):881-90. PubMed ID: 18757828
[TBL] [Abstract][Full Text] [Related]
20. [Regulation of PI3K-Akt-GSK3β signaling pathway in U251 cells by risperidone].
Liang L; Wang Y; Wei J; Gu X; Xiang B; Ma X; Li T
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Dec; 31(6):693-7. PubMed ID: 25449069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
